Studies have also demonstrated changes in other inflammatory markers, including fibrinogen, plasminogen activator inhibitor-1 (PAI-1), and various adhesion molecules involved in vascular inflammation
Weight Loss Efficacy Against Safety Considerations Tirzepatide achieves 20-22% body weight reduction over 68 weeks, exceeding semaglutide's 17-18% reduction while maintaining comparable serious adverse event rates
Understanding your genetic peptide profile helps you set realistic expectations and celebrate progress that matches your biology rather than comparing yourself to others
The semaglutide first week guide walks through the physiological changes that happen early in treatment, which helps set realistic expectations for what youll actually feel in those first days
If you or a close family member has previously experienced DVT, PE, or other thrombotic events, your baseline risk is already elevated